Cite
Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study
MLA
Yoshiyuki Sano, et al. “Impact of Concomitant Medication on Clinical Outcomes in Patients with Advanced Non‐small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Study.” Thoracic Cancer, vol. 12, no. 13, July 2021, pp. 1983–94. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c0511a7df70950187195436791b5a81e&authtype=sso&custid=ns315887.
APA
Yoshiyuki Sano, Kaname Nosaki, Kenji Kawasumi, Shingo Matsumoto, Kazuhiko Hanada, Toshikatsu Kawasaki, Nobuo Mochizuki, Yoshitaka Zenke, Hibiki Udagawa, Kiyotaka Yoh, Takaya Ikeda, Seiji Niho, Koichi Goto, Kaho Miura, & Keisuke Kirita. (2021). Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study. Thoracic Cancer, 12(13), 1983–1994.
Chicago
Yoshiyuki Sano, Kaname Nosaki, Kenji Kawasumi, Shingo Matsumoto, Kazuhiko Hanada, Toshikatsu Kawasaki, Nobuo Mochizuki, et al. 2021. “Impact of Concomitant Medication on Clinical Outcomes in Patients with Advanced Non‐small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Study.” Thoracic Cancer 12 (13): 1983–94. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c0511a7df70950187195436791b5a81e&authtype=sso&custid=ns315887.